Comparative field study evaluating the activity of recombinant Factor IX - Fc fusion protein (rFIXFc) in plasma samples at clinical haemostasis laboratories

被引：0
|
作者：
Sommer, J. [1 ]
Buyue, Y. [1 ]
Peters, R. T. [1 ]
Jiang, H. [1 ]
Gray, E. [2 ]
Pierce, G. F. [1 ]
机构：
[1] Biogen Idec Hemophilia, Waltham, MA USA
[2] NIBSC, Potters Bar, Herts, England
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：828 / 829
页数：2
相关论文
共 50 条
  • [31] Clinical Outcomes in Adults/Adolescents with Hemophilia B Treated Long Term with Recombinant Factor IX Fc Fusion Protein (rFIXFc) Prophylaxis: Interim Results of the B-Yond Extension Study
    Matsushita, Tadashi
    Mahlangu, Johnny
    Shapiro, Amy D.
    Pasi, K. John
    Ragni, Margaret V.
    Ozelo, Margareth C.
    Oldenburg, Johannes
    Baker, Ross I.
    Yuan, Huixing
    Ramirez-Santiago, Alejandra
    Ferrante, Francesca
    Lethagen, Stefan
    BLOOD, 2016, 128 (22)
  • [32] Biodistribution of recombinant factor IX, extended half-life recombinant factor IX Fc fusion protein, and glycoPEGylated recombinant factor IX in hemophilia B mice
    van der Flier, Arjan
    Hong, Vu
    Liu, Zhan
    Piepenhagen, Peter
    Ulinski, Gregory
    Dumont, Jennifer A.
    Orcutt, Kelly D.
    Goel, Apollina
    Peters, Robert
    Salas, Joe
    BLOOD COAGULATION & FIBRINOLYSIS, 2023, 34 (06) : 353 - 363
  • [33] Physical activity in individuals with haemophilia and experience with recombinant factor VIII Fc fusion protein and recombinant factor IX Fc fusion protein for the treatment of active patients: a literature review and case reports
    Wang, Michael
    Teresa Alvarez-Roman, Maria
    Chowdary, Pratima
    Quon, Doris V.
    Schafer, Kim
    BLOOD COAGULATION & FIBRINOLYSIS, 2016, 27 (07) : 737 - 744
  • [34] Post hoc analysis to evaluate the effect of recombinant factor IX Fc fusion protein (rFIXFc) prophylaxis in adults and adolescents with target joints and hemophilia B
    Kulkarni, Roshni
    Pasi, K. John
    Liesner, Raina
    Hanabusa, Hideji
    Feng, Jingyuan
    Ferrante, Francesca
    Mei, Baisong
    Jain, Nisha
    HAEMOPHILIA, 2016, 22 : 44 - 44
  • [35] Continuous prophylaxis with recombinant factor IX Fc fusion protein and conventional recombinant factor IX products: comparisons of efficacy and weekly factor consumption
    Iorio, Alfonso
    Krishnan, Sangeeta
    Myren, Karl-Johan
    Lethagen, Stefan
    McCormick, Nora
    Yermakov, Sander
    Karner, Paul
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (04) : 337 - 344
  • [36] Treatment of bleeding episodes in subjects with haemophilia B with the long-lasting recombinant factor IX Fc fusion protein (rFIXFc) in the phase 3 B-LONG study
    Pasi, J.
    Josephson, N.
    Mahlangu, J.
    Perry, D.
    Powell, J.
    Ragni, M.
    Valentino, L. A.
    Krassova, S.
    Nugent, K.
    Brennan, A.
    Innes, A.
    Luk, A.
    Pierce, G. F.
    Allen, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 359 - 359
  • [37] Long Term Safety and Efficacy of Recombinant Factor IX Fc Fusion Protein (rFIXFc) Prophylaxis in Children with Hemophilia B: Interim Results of the B-Yond Extension Study
    Ducore, Jonathan M.
    Fischer, Kathelijn
    Kulkarni, Roshni
    Nolan, Beatrice
    Bennett, Carolyn M.
    Perry, David J.
    Yuan, Huixing
    Ramirez-Santiago, Alejandra
    Ferrante, Francesca
    Lethagen, Stefan
    BLOOD, 2016, 128 (22)
  • [38] Extended-Interval Prophylaxis with Recombinant Factor IX FC Fusion Protein (rFIXFc) in Adults/Adolescents with Haemophilia B: Interim Results of the B-YOND Extension Study
    Mahlangu, J.
    Shapiro, A. D.
    Pasi, K. J.
    Ragni, M. V.
    Ozelo, M. C.
    Oldenburg, J.
    Matsushita, T.
    Baker, R. I.
    Yuan, H.
    Ramirez-Santiago, A.
    Pierce, G. F.
    Allen, G.
    Mei, B.
    HAEMOPHILIA, 2016, 22 : 46 - 47
  • [39] INTERNATIONAL ASSESSMENT OF RECOMBINANT FACTOR IX FC FUSION PROTEIN CLOTTING ACTIVITY AT VARIOUS HEMOPHILIA TREATMENT CENTERS
    Geske, F. Jon
    Sadeghi-Khomami, Ali
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (09) : E411 - E412
  • [40] Individualised Prophylaxis In Children With Haemophilia B Treated Long Term With Recombinant Factor Ix Fc Fusion Protein (RFIXFC): Updated Interim Results Of The B-YOND Extension Study
    Fischer, K.
    Kulkarni, R.
    Nolan, B.
    Bennett, C. M.
    Perry, D. J.
    Barnes, C.
    Yuan, H.
    Ramirez-Santiago, A.
    Ferrante, F.
    Dumont, J.
    Lethagen, S.
    Barnowski, C.
    HAEMOPHILIA, 2017, 23 : 94 - 94
12345